JnanaTherapeutics_Logo_FullColor_RGB.png
Jnana Therapeutics to Present at the RBC Capital Markets Healthcare Private Company Virtual Conference
06 déc. 2023 08h00 HE | Jnana Therapeutics, Inc.
Jnana Therapeutics CEO Joanne Kotz will participate in a fireside chat on Dec. 13 at the RBC Capital Markets Healthcare Private Company Conference.
JnanaTherapeutics_Logo_FullColor_RGB.png
Jnana Therapeutics to Participate in Upcoming Investor Conferences
05 oct. 2023 08h00 HE | Jnana Therapeutics, Inc.
BOSTON, Oct. 05, 2023 (GLOBE NEWSWIRE) -- Jnana Therapeutics, a biotechnology company leveraging its next-generation chemoproteomics platform to discover medicines for challenging-to-drug targets,...
JnanaTherapeutics_Logo_FullColor_RGB.png
Jnana Therapeutics to Participate in Upcoming Investor Conferences
06 sept. 2023 08h00 HE | Jnana Therapeutics, Inc.
BOSTON, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Jnana Therapeutics, a biotechnology company leveraging its next-generation chemoproteomics platform to discover medicines for challenging-to-drug targets,...
JnanaTherapeutics_Logo_FullColor_RGB.png
Jnana Therapeutics Announces Milestone Achieved Under First Collaboration with Roche
24 mai 2023 07h00 HE | Jnana Therapeutics, Inc.
Achievement of research milestone for immune program triggers milestone payment BOSTON, May 24, 2023 (GLOBE NEWSWIRE) -- Jnana Therapeutics, a clinical-stage biotechnology company leveraging its...